Los datos de carácter personal que consten en la consulta serán tratados por BIOITHAS, S.L. e incorporados a la actividad de tratamiento CONTACTOS, cuya finalidad es atender tus solicitudes, peticiones o consultas recibidas desde la web, mediante correo electrónico o telefónico. Dar respuesta a tu solicitud y hacer un seguimiento posterior.
La legitimación del tratamiento es tu consentimiento. Tus datos no serán cedidos a terceros. Tienes derecho a acceder, rectificar y suprimir tus datos, así como otros derechos como se explica en nuestra política de privacidad: https://www.adelopd.com/privacidad/bioithas-sl
Rellena con tus datos y nos pondremos en contacto contigo.
Scientific articles
Below, we detail the scientific articles published and led by our scientific director Vicente Navarro López, in several of the most important indexed journals in the world.
QUALIFICATION | PUBLICATION |
Descriptive Study of Gut Microbiota in Infected and Colonized Subjects by Clostridiodes difficile | Microorganisms, 2021; 9(8):1727. doi: 10.3390/microorganisms9081727. |
Probiotics in the Therapeutic Arsenal of Dermatologists | Microorganisms, 2021; 9(7):1513. doi: 10.3390/microorganisms9071513. |
Study of the Vaginal Microbiota in Healthy Women of Reproductive Age | Microorganisms, 2021; 9(5):1069. doi: 10.3390/microorganisms9051069. |
Changes in Gut Microbiota Correlates with Response to Treatment with Probiotics in Patients with Atopic Dermatitis. A Post Hoc Analysis of a Clinical Trial. |
Microorganisms, 2021; 9(4): 854, doi: 10.3390/microorganisms9040854. |
Efficacy and Safety of Oral Administration of a Mixture of Probiotic Strains in Patients with Psoriasis: a Randomized Clinical Trial. |
Acta Dermato-Venereologica, 2019; 99(12): 1078-1084, doi:10.2340/00015555-3305. |
Gut microbial composition in patients with psoriasis. |
Scientific Reports, 2018; 8(1): 3812, doi: 10.1038/s41598-018-22125-y. |
Others
Intestinal microbiota as a new prognostic factor for relapsing-remitting multiple sclerosis. “LXXII Annual Meeting of the Spanish Society of Neurology”, 11/23/2020 – 12/03/2020.
Salivary microbiota as a proposed diagnostic biomarker in head and neck cancer. “XI Workshop of the Spanish Society of Microbiota, Probiotics and Prebiotics (SEMiPyP)”. Granada, 02/07/2020 – 02/09/2020.
A new target for the treatment of acne vulgaris. Pilot research study. AEDV 2019, 47th National Congress of Dermatology and Venereology. Barcelona, 06/05/2019 – 06/08/2019.
Randomized double-blind placebo-controlled clinical trial to evaluate the safety and effect of a probiotic mixture on the PASI index in patients with moderate psoriasis. AEDV 2018, 46th National Congress of Dermatology and Venereology. Palma de Mallorca, 09/0/2018 – 05/12/2018.
Alpha diversity study in patients with Clostridium difficile infection and asymptomatic carriers. X Workshop of the Spanish Society of Probiotics and Preb'iotics (SEPyP). Las Palmas de Gran Canaria, 02/06/2019 – 02/08/2019 Spanish Society of Probiotics and Prebiotics (SEPyP).
Research Patronage Award 2019. Awarded by the Social Council of the University of Alicante.
National Research Award, Pfizer Chair in Psoriasis, Autonomous University of Madrid 2015. Bacterial Translocation in a case series of patients with psoriasis.
Best Research Project by the Spanish Society of Dermatology during 2015. Bacterial Translocation in a case series of patients with psoriasis.
Access to the best national clinical research work with the use of probiotics. Atopic dermatitis. A randomized clinical trial. National Congress of the Spanish Society of Probiotics and Prebiotics. SEPYP Workshop 2017
National Award for the best clinical research work with oral communication. Psoriasis. A randomized clinical trial. National Congress of the Spanish Society of Probiotics and Prebiotics, Workshop SEPYP 2018
Award for the best Oral Communication of clinical uses. Multiple sclerosis and microbiota. Original Investigation. Spanish Society of Probiotics and Prebiotics, SEPYP 2019 Workshop.
National Award: access to the best work in poster format. Differences in the intestinal microbiota of asymptomatic and symptomatic carrier patients with clostridium difficile infection. Study of a cohort of patients.